• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发用于 PD1 检测的选择性 ssDNA 微探针作为癌症成像的新策略。

Development of selective ssDNA micro-probe for PD1 detection as a novel strategy for cancer imaging.

机构信息

Laboratory of Proteolysis and Post-translational Modification of Proteins, Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, Krakow, 30-387, Poland.

Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, Krakow, 30-387, Poland.

出版信息

Sci Rep. 2024 Nov 19;14(1):28652. doi: 10.1038/s41598-024-74891-7.

DOI:10.1038/s41598-024-74891-7
PMID:39562585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11576874/
Abstract

Programmed death receptor 1, PD1, modulates the function of immune cells by providing inhibitory signals and constitutes the marker of immune exhaustion. Monitoring the level of PD1 promises a useful diagnostic approach in autoimmune diseases and cancer. Here we describe the development of an ssDNA aptamer-based molecular probe capable of specific recognition of human PD1 receptor. The aptamer was selected using SELEX, its sequence was further optimized, and the affinity and specificity were determined in biochemical assays. The aptamer was converted into a fluorescent probe and its potential in molecular imaging was demonstrated in a culture of human cells overexpressing PD1 and murine pancreatic organoids / immune cells mixed co-culture model. We conclude that the provided aptamers are suitable probes for imaging of PD1 expressing immune cells even in complex cellular models and may find future utility as diagnostic tools.

摘要

程序性死亡受体 1(PD1)通过提供抑制信号来调节免疫细胞的功能,是免疫衰竭的标志物。监测 PD1 的水平有望成为自身免疫性疾病和癌症的一种有用的诊断方法。在这里,我们描述了一种基于单链 DNA(ssDNA)适体的分子探针的开发,该探针能够特异性识别人 PD1 受体。该适体通过 SELEX 筛选得到,其序列进一步优化,并在生化测定中确定了亲和力和特异性。将适体转化为荧光探针,并在过表达 PD1 的人细胞培养物和混合共培养的小鼠胰腺类器官/免疫细胞模型中证明了其在分子成像中的应用潜力。我们得出结论,所提供的适体是用于成像表达 PD1 的免疫细胞的合适探针,即使在复杂的细胞模型中也是如此,并且可能作为诊断工具具有未来的应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/671ddf3326b9/41598_2024_74891_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/eb53d1094543/41598_2024_74891_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/889056d365ef/41598_2024_74891_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/03241e99046c/41598_2024_74891_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/a0d06837bb41/41598_2024_74891_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/80fbada69e2a/41598_2024_74891_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/671ddf3326b9/41598_2024_74891_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/eb53d1094543/41598_2024_74891_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/889056d365ef/41598_2024_74891_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/03241e99046c/41598_2024_74891_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/a0d06837bb41/41598_2024_74891_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/80fbada69e2a/41598_2024_74891_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac86/11576874/671ddf3326b9/41598_2024_74891_Fig6_HTML.jpg

相似文献

1
Development of selective ssDNA micro-probe for PD1 detection as a novel strategy for cancer imaging.开发用于 PD1 检测的选择性 ssDNA 微探针作为癌症成像的新策略。
Sci Rep. 2024 Nov 19;14(1):28652. doi: 10.1038/s41598-024-74891-7.
2
Development and Evaluation of Novel Aptamers Specific for Human PD1 Using Hybrid Systematic Evolution of Ligands by Exponential Enrichment Approach.利用杂交指数富集配体系统进化技术(SELEX)开发并评估针对人 PD1 的新型适体。
Immunol Invest. 2020 Jul;49(5):535-554. doi: 10.1080/08820139.2020.1744639. Epub 2020 May 19.
3
Generating lung-metastatic osteosarcoma targeting aptamers for in vivo and clinical tissue imaging.生成用于体内和临床组织成像的肺转移骨肉瘤靶向适体。
Talanta. 2018 Oct 1;188:66-73. doi: 10.1016/j.talanta.2018.05.011. Epub 2018 May 18.
4
Nucleic Acid Aptamers as Emerging Tools for Diagnostics and Theranostics.核酸适配体作为诊断与治疗诊断学的新兴工具。
Methods Mol Biol. 2019;2054:201-221. doi: 10.1007/978-1-4939-9769-5_14.
5
CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2.CS-SELEX 产生高亲和力的 ssDNA 适体作为丙型肝炎病毒包膜糖蛋白 E2 的分子探针。
PLoS One. 2009 Dec 3;4(12):e8142. doi: 10.1371/journal.pone.0008142.
6
In vivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX.利用细胞 SELEX 生成的分子适体进行肿瘤的体内荧光成像。
Chem Asian J. 2010 Oct 4;5(10):2209-13. doi: 10.1002/asia.201000242.
7
Isolation of a new ssDNA aptamer against staphylococcal enterotoxin B based on CNBr-activated sepharose-4B affinity chromatography.基于溴化氰活化的琼脂糖凝胶4B亲和色谱法分离一种针对葡萄球菌肠毒素B的新型单链DNA适配体。
J Mol Recognit. 2016 Sep;29(9):436-45. doi: 10.1002/jmr.2542. Epub 2016 Apr 19.
8
Two-plex molecular imaging in the second near-infrared window for immunotherapeutic response.用于免疫治疗反应监测的第二近红外窗口双分子成像
Theranostics. 2025 Mar 19;15(10):4481-4494. doi: 10.7150/thno.108880. eCollection 2025.
9
An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.基于适体的乳腺癌分子分型探针。
Theranostics. 2018 Nov 10;8(20):5772-5783. doi: 10.7150/thno.28949. eCollection 2018.
10
Identification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2.鉴定、表征和应用针对癌症生物标志物蛋白前梯度同源物 2 的 G-四链体结构 DNA 适体。
PLoS One. 2012;7(9):e46393. doi: 10.1371/journal.pone.0046393. Epub 2012 Sep 28.

本文引用的文献

1
Bispecific Aptamer-Based Recognition-then-Conjugation Strategy for PD1/PDL1 Axis Blockade and Enhanced Immunotherapy.基于双特异性适配体的先识别后偶联策略用于PD1/PDL1轴阻断及增强免疫治疗
ACS Nano. 2022 Dec 27;16(12):21129-21138. doi: 10.1021/acsnano.2c09093. Epub 2022 Dec 9.
2
Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe.基于免疫检查点靶向适体的探针用于透明细胞肾细胞癌的成像
Pharmaceuticals (Basel). 2022 Jun 1;15(6):697. doi: 10.3390/ph15060697.
3
DNA aptamer S11e recognizes fibrosarcoma and acts as a tumor suppressor.
DNA适配体S11e可识别纤维肉瘤并发挥肿瘤抑制作用。
Bioact Mater. 2021 Oct 15;12:278-291. doi: 10.1016/j.bioactmat.2021.10.011. eCollection 2022 Jun.
4
In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies.在 PD-1+ 人结肠癌细胞中,NIVOLUMAB 促进了肿瘤细胞的存活,并能保护肿瘤细胞免受常规疗法的杀伤。
J Immunother Cancer. 2022 Mar;10(3). doi: 10.1136/jitc-2021-004032.
5
Evaluation of I-JS001 for hPD1 immuno-PET imaging using sarcoma cell homografts in humanized mice.在人源化小鼠中使用肉瘤细胞同种异体移植评估I-JS001用于hPD1免疫PET成像。
Acta Pharm Sin B. 2020 Jul;10(7):1321-1330. doi: 10.1016/j.apsb.2020.02.004. Epub 2020 Feb 19.
6
Development and Evaluation of Novel Aptamers Specific for Human PD1 Using Hybrid Systematic Evolution of Ligands by Exponential Enrichment Approach.利用杂交指数富集配体系统进化技术(SELEX)开发并评估针对人 PD1 的新型适体。
Immunol Invest. 2020 Jul;49(5):535-554. doi: 10.1080/08820139.2020.1744639. Epub 2020 May 19.
7
The Role of PD-1 in Acute and Chronic Infection.PD-1 在急性和慢性感染中的作用。
Front Immunol. 2020 Mar 24;11:487. doi: 10.3389/fimmu.2020.00487. eCollection 2020.
8
Development of a Novel DNA Oligonucleotide Targeting Low-Density Lipoprotein Receptor.一种靶向低密度脂蛋白受体的新型DNA寡核苷酸的研发
Mol Ther Nucleic Acids. 2020 Mar 6;19:190-198. doi: 10.1016/j.omtn.2019.11.004. Epub 2019 Nov 16.
9
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors.程序性死亡配体 1(PD-L1)表达作为预测生物标志物的作用:对所有美国食品和药物管理局(FDA)批准的免疫检查点抑制剂的分析。
J Immunother Cancer. 2019 Oct 26;7(1):278. doi: 10.1186/s40425-019-0768-9.
10
Development of Tc-conjugated JS001 antibody for in vivo mapping of PD-1 distribution in murine.Tc 标记 JS001 抗体用于在体检测小鼠 PD-1 分布
Bioorg Med Chem Lett. 2019 Aug 15;29(16):2178-2181. doi: 10.1016/j.bmcl.2019.06.019. Epub 2019 Jun 17.